Epidemiology of Non-Alcoholic Fatty Liver Disease

10 May 2010Bellentani S. · Scaglioni F. · Marino M. · Bedogni G.

Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits.

Meta Analysis
3 effects

Reported Outcomes

DeterminantsOutcomeDetails

Type 2 Diabetes Lymphatic outcome
Type 2 Diabetes
Lymphatic system

Non Fatty Liver Disease Digestive outcome
Increased risk of Non Fatty Liver Disease
Digestive system

High evidence
40.0%

Diabetes Lymphatic outcome
Diabetes
Lymphatic system

Non Fatty Liver Disease Digestive outcome
Increased risk of Non Fatty Liver Disease
Digestive system

High evidence
40.0%

Obesity Musculoskeletal outcome
Obesity
Musculoskeletal system

Non Fatty Liver Disease Digestive outcome
Increased risk of Non Fatty Liver Disease
Digestive system

High evidence
85.0%